000 01241 a2200337 4500
005 20250512134726.0
264 0 _c19660731
008 196607s 0 0 eng d
022 _a0002-9629
024 7 _a10.1097/00000441-196605000-00008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNeumann, M
245 0 0 _aDouble blind evaluation of orally administered iproveratril in patients with angina pectoris.
_h[electronic resource]
260 _bThe American journal of the medical sciences
_cMay 1966
300 _a552-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAged
650 0 4 _aAngina Pectoris
_xdrug therapy
650 0 4 _aAnti-Arrhythmia Agents
_xpharmacology
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNitroglycerin
_xtherapeutic use
650 0 4 _aPlacebos
650 0 4 _aVasodilator Agents
_xpharmacology
650 0 4 _aVerapamil
_xpharmacology
700 1 _aLuisada, A A
773 0 _tThe American journal of the medical sciences
_gvol. 251
_gno. 5
_gp. 552-6
856 4 0 _uhttps://doi.org/10.1097/00000441-196605000-00008
_zAvailable from publisher's website
999 _c4959282
_d4959282